Related Experiment Video
Updated: Sep 16, 2026

Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue
Published on: February 24, 2023
Rheumatoid arthritis: proposal for the use of anti-microbial therapy in early cases
Alan Ebringer1, Taha Rashid, Clyde Wilson
1Division of Life Sciences, Infection and Immunity Group, King's College London, UK. alan.ebringer@kcl.ac.uk
Abstract:
Rheumatoid arthritis (RA) is a chronic disease, affecting women more than men, especially in those possessing the "shared epitope" (EQK/RRAA) amino acid sequences present in HLA-DR1/4 molecules. Proteus mirabilis carries sequences showing molecular mimicry to the "shared epitope" and to type XI collagen of hyaline cartilage. Elevated levels of antibodies to P. mirabilis have been reported from 14 different countries involving 1375 RA patients and the microbe has been isolated from urine cultures of such patients. Our working hypothesis is that the disease develops as a result of repeated episodes of Proteus upper urinary tract infections. Prospective studies involving the trial of anti-Proteus measures in RA patients should be evaluated in the management of this disease. Antibiotics, high fluid intake, and fruit extracts, such as cranberry juice, have all been found to be effective in the treatment of urinary tract infections. Such measures could be used as possible additional adjuncts to the standard therapy with NSAIDs and DMARDs.
Insights
Rheumatoid arthritis (RA) may stem from Proteus urinary tract infections. Targeting this bacteria with antibiotics or cranberry may aid RA management alongside standard treatments.
Area of Science:
- Immunology
- Microbiology
- Rheumatology
Background:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease disproportionately affecting women.
- RA pathogenesis is linked to HLA-DR molecules with specific
- shared epitope
- amino acid sequences (EQK/RRAA).
- Proteus mirabilis exhibits molecular mimicry to the
- shared epitope
- and hyaline cartilage collagen.
Purpose of the Study:
- To investigate the hypothesis that recurrent Proteus upper urinary tract infections contribute to rheumatoid arthritis development.
- To explore potential adjunctive therapies for RA management targeting Proteus infections.
Main Methods:
- Review of existing studies reporting elevated antibodies to P. mirabilis in RA patients (1375 patients across 14 countries).
- Analysis of P. mirabilis isolation from RA patient urine cultures.
- Evaluation of anti-Proteus measures for potential RA management.
Main Results:
- Elevated antibodies to P. mirabilis were found in a significant number of RA patients globally.
- P. mirabilis was isolated from urine cultures of RA patients.
- Anti-Proteus measures like antibiotics, hydration, and cranberry extracts show efficacy in urinary tract infection treatment.
Conclusions:
- Recurrent Proteus upper urinary tract infections are a plausible etiological factor in rheumatoid arthritis.
- Anti-Proteus strategies could serve as supplementary treatments for RA.
- Further prospective studies are warranted to evaluate anti-Proteus measures in RA management.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Microorganisms in Medicine and Therapeutics
Microbiota Modulation by Antibiotics

